---
category: news
title: "Abbott (ABT) Receives FDA Approval for OCT Imaging Platform"
excerpt: "Abbott Laboratories ABT recently received the FDA go-ahead for its latest optical coherence tomography (OCT) imaging platform, powered by the company's new Ultreon Software. The Ultreon Software is a first-of-its-kind imaging software that combines OCT with artificial intelligence (AI)."
publishedDateTime: 2021-08-04T14:43:00Z
originalUrl: "https://www.nasdaq.com/articles/abbott-abt-receives-fda-approval-for-oct-imaging-platform-2021-08-04"
webUrl: "https://www.nasdaq.com/articles/abbott-abt-receives-fda-approval-for-oct-imaging-platform-2021-08-04"
type: article
quality: 34
heat: 34
published: false

provider:
  name: Nasdaq
  domain: nasdaq.com

topics:
  - AI in Healthcare
  - AI

related:
  - title: "Abbott Receives FDA Clearance For Its Imaging Technology Using Artificial Intelligence For Vessels in the Heart"
    excerpt: "Abbott (NYSE: ABT) today announced it has received U.S. Food and Drug Administration (FDA) clearance for its latest optical coherence tomography (OCT) imaging platform powered by the company's new Ultreon Software."
    publishedDateTime: 2021-08-04T08:12:00Z
    webUrl: "https://www.pharmiweb.com/pwtoday-story/abbott-receives-fda-clearance-for-its-imaging-technology-using-artificial-intelligence-for-vessels-in-the-heart"
    type: article
    provider:
      name: PharmiWeb
      domain: pharmiweb.com
    quality: 19
    images:
      - url: "https://cdn.pharmiweb.com/media/13040/abbott_300x400-1.jpg"
        width: 300
        height: 400
        isCached: true

secured: "Ny4H5zXv+Ay/7y7YF7kMHgH42wpWZFBRtcyrMgAbyEXW8dWhcupXNX/WEScBXKHjQ+3BkTIpMqiBi2Pq94hKOOGBGq2MOV4+aoRpCvUDVgYHHcQ4QjNg9Nd1rfXu5b5HnjeX5I4Wg5jhSSWP6Tvmr8Rlmx/QGrU+aPYiwU5TfQ+Krzthy9P4UTjhd+lSC3Ssyhh79gl/BWAfNOipyZeEBgDKVh590UIGLVJcgHnS7iTkBdUMzVXBAi7C84P5oSku7zRtQDF1LVRztAOAw3EqMFpwqpl5iofWkhOUPckNWrZcHdoxFKlFAz4uqIi5UUExjqn5XfeyYUz3Z9U7lEgy44c6koHoj0txvNogbUkDYTw=;O6TEFprNPmPjJF7crsCy3Q=="
---

